Cecelia Calhoun was named assistant professor of medicine (hematology) and assistant professor of pediatrics (hematology/oncology) at Yale Cancer Center and Smilow Cancer Hospital.
Reverend Melody Rutherford was named Roswell Park Comprehensive Cancer Center’s Director of Spiritual Care, following a national search.
A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from NIH to identify new ways to treat pancreatic cancer.
A team of researchers from four New York institutions have received $6 million from Stand Up to Cancer to address the low participation of Black, Indigenous and People of Color in cancer clinical trials.
City of Hope and its nursing team have achieved Magnet recognition from the American Nurses Credentialing Center.
Led by the University of California, Irvine, UC hospitals have received a $500,000 grant from NIH to transfer UC information on COVID-19 cases into the National COVID Cohort Collaborative’s centralized data resource at NIH’s National Center for Advancing Translational Sciences.
University of California Davis Comprehensive Cancer Center was named the 31st Member Institution of The National Comprehensive Cancer Network.
The Clear Your View initiative is expanding its focus to colorectal cancer to raise awareness of the important role complete biomarker testing plays in guiding initial treatment decisions for newly diagnosed advanced colorectal cancer patients.
A story in the March 19 issue of The Cancer Letter stated that the deadline for project proposals—from intramural and extramural investigators applying for clinical grade vector and cell therapy product manufacturing at Frederick National Laboratory—is in July 2021. According to updated information from NCI, the next deadline is June 15. jQuery(document).ready(function(){ jQuery('.people-thumb + p > span.has-red-100-color, .people-thumb + p >... […]
Hackensack Meridian Health and the Genomic Testing Cooperative are establishing a genomic profiling laboratory called Anthology Diagnostics, to generate more personalized, precise, and real-time insights for cancer patients, oncologists and hospitals.
